... As we know from the Sinclair/de Cabo report (3), high-dose resveratrol does help to partially normalize the lives of such animals -- but it doesn't do much -- and, in terms of mortality, doesn't do anything -- for normally-fed. normal-weight mice. ...
What did the mice die of? "...the vast majority of these cases were lymphomas, a tumor type for which the efficacy of resveratrol has not been thoroughly assessed, and that is thought to be triggered mainly by endogenous retroviruses in mice..." The C57B mice used in de Cabos study are infected with an endogenous retrovirus. If the lab had burned down in a fire, one could as well declare resveratrol did not extend life-span because the mice all died in the fire.
Max, did you read the full paragraph from which you're quoting?
Histopathology Blinded postmortem histopathology for disease or predisease states was performed on visceral organs including the heart, kidneys, liver, spleen, lungs, and pancreas (Table S3). Resveratrol treatment did not significantly alter the distribution of pathologies in SD groups. This included neoplasias, despite the potency of resveratrol against implanted or chemically induced tumors, recently reviewed elsewhere (Baur and Sinclair, 2006). This may be related to the fact that the vast majority of these cases were lymphomas, a tumor type for which the efficacy of resveratrol has not been thoroughly assessed, and that is thought to be triggered mainly by endogenous retroviruses in mice (Kaplan, 1967; Risser et al., 1983). ((1); my emphasis)
Above, you
seem to be mistaking them to mean that .the vast majority of
deaths in C57Bl/6 mice are caused by lymphomas, which if you read that quote in context, it's clear that they aren't saying (and in any case isn't true). Rather, "these cases" refers to
neoplasia. They're saying that the majority
of the cancers in their study were lymphomas, of which the majority in turn are thought to be caused by ERVs. If you look at their Table S3, you'll see that "only" about half of the mice died from
any form of cancer, which isn't much lower than the rate in humans (and remember that mice don't naturally get heart disease) -- and some proportion
of these in turn are lymphomas (they don't break this down).
The mice died of all kinds of things, IOW (notably, other cancers, kidney disease, and (in the obese, high-sucrose-high-saturated-fat-fed mice (the ones that first raised the hype factor on resverarol) fatty liver), not just lymphomas -- it's just that lymphoma is the
single biggest cause of cancer, which latter is the
single biggest cause of death.
Note also that resveratrol didn't just fail to protect them from lymphomas, but that "Resveratrol treatment did not significantly alter the distribution of " "histopathology for disease or predisease states ... [in] visceral organs including the heart, kidneys, liver, spleen, lungs, and pancreas (Table S3)" in the animals fed a normal diet.
The C57B mice used in de Cabos study are infected with an endogenous retrovirus. If the lab had burned down in a fire, one could as well declare resveratrol did not extend life-span because the mice all died in the fire.
Do remember that every mammal on the planet is infected with an endogenous retrovirus
. "Endogenous retroviruses (ERVs) constitute approximately 8-10% of the human and mouse genome." (2)
So many substances have been tested for life-extension using C57B mice, and have come up short. It looks to me the reason is that unless the substance protects against lymphoma, the mice will die of that before other life-extending effects are manifest. We have a flawed model for testing life-extension.
Well, I do agree with this to a point -- but anything short of human testing is always flawed in some sense. The question isn't whether these mice die of something more often than something else (this is true of any model!): the question is whether they die
early in some artificial way. The C57Bl/6 is used so often in large part because for a mouse it is very long-lived: C57Bl/6 live longer than other strains precisely because they
don't die earlier of other causes. You've gotta die of
something ...
While (6) wasn't a lifespan study, it used the more genetically-diverse hybrid of C57BL/6Å~C3H/HeF1, and still found "no decrease in spontaneous tumors at the time of sacrifice (Supplemental Table S2). In particular,
spontaneous liver tumors were
abundant in mice fed the control diet or resveratrol, but rare in CR mice."
All that said:
N.B. CR (including EOD feeding) is known to protect against lymphomas. Resveratrol does not. De Cabo found EOD feeding plus resveratrol mice lived longer than the EOD alone group. It is possible that EOD protected against lymphoma in these groups, and the addition of resveratrol extended life-span beyond what EOD alone did by other mechanisms.
Yup, an entirely plausible hypothesis -- although it's worth noting that nominally, at least,
more of the EOD-fed animals died of cancer than AL animals did (though the difference (60% vs 50%) wasn't significantly different, and again, we don't have the breakdown on
lymphomas specifically). The major reductions in death were in kidney disease and in "other."
The EOD-plus-lower-dose-resveratrol group had about the cancer incidence of AL animals -- it's just that they took longer to develop it.
Again, you've gotta die of
something.
Despite what I say above and elsewhere, I am still following the resveratrol story, and am glad to know that NIA's ITP is also testing the stuff, and doing so in a more genetically-heterogeneous stock. This has its pros and cons, but these mice do have a nice, long life and a diversity of causes of death. (Unfortunately, AFAICS, they aren't repeating the combined EOD-plus-res part of (1), nor, as would IMO be better yet, combining it with a higher, but submaximal, level of CR).
But to those taking more supplemental resveratrol than is present a moderate intake of wine a day
right now, before such studies are completed, I ask: where is the
better evidence on which you're gambling your long-term health? We have no evidence of extension of life in any mammal -- just the
near-normalization of
premature mortality in animals rendered obese and diabetic because of a life gorging on a high-sucrose, high-saturated-fat diet. Of note, (8) found (similarly to Auwerx and de Cabo) that resveratrol gave significant protection to obese, high-fat-diet fed Wistar
rats (not mice, let alone C57Bl/6) against "hyperglycaemia, dyslipidemia, increased serum oxidized-LDL (ox-LDL) and hepatic oxidative stress," it gave no such benefits to normal-weight, normal-diet rats: in fact, resveratrol supplementation of "standard-fed-rats
reduced glutathione-antioxidant defense system and
enhanced hepatic lipid hydroperoxide [my emphasis]." Above, remember, just such a diabetic, obese, junkfood-died rodent model study (Auwerx) was favorably referenced as evidence of the safety of resveratrol!
In mice, resveratrol doesn't fully replicate CR-induced gene expression changes (6) nor induce some demonstrably important CR-induced metabolic changes (7). Heck, it's not even clear that the stuff does any good in yeast (where the whole hype got started) (3); nor in
Drosophila elegans (note that Partridge's group is possibly the most experienced lab in the world in doing lifespan studies in
Drosophila) (4); nor in another (tephritid) species of fruit flies ((5): there may have been a marginal effect in flies fed 1 of the 24 different diet combinations, but I'm skeptical of that result, and IAC there was no effect in the other 23 diets); nor in
C. elegans (4) -- and in mammals, again, the evidence to date is
against it, except as a complementary intervention in animals also on mild EOD CR.
There are no studies on the safety of resveratrol in humans lasting even a few
months, and there what appear to me to be a
disturbing number of
independent reports of
joint pain. These are anecdotal, of course, and could be coincidental, but they aren't the standard headaches-and-upset-tummies stuff, and there seem to be an awful lot of them. Even if you aren't getting this pain, if it's real, the unknown mechanism leaves open the question of unknown other, more subtle or long-term effects in humans.
Again, I challenge you folks to seriously ask: on what evidential basis are you gambling your health on this stuff?
-Michael
1. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R.
Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span.
Cell Metab. 2008 Aug;8(2):157-68.
PMID: 18599363 [PubMed - as supplied by publisher]
2. Lee YK, Chew A, Phan H, Greenhalgh DG, Cho K. Genome-wide expression profiles of endogenous retroviruses in lymphoid tissues and their biological properties. Virology. 2008 Apr 10;373(2):263-73. Epub 2008 Jan 9. PubMed PMID: 18187179; PubMed Central PMCID: PMC2427371.
3. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell S, Napper A, Curtis R, Distefano PS, Fields S, Bedalov A, Kennedy BK.
Substrate specific activation fo sirtuins by resveratrol.
J Biol Chem. 2005 Jan 31; [Epub ahead of print]
PMID: 15684413
4. Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L.
Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans.
Mech Ageing Dev. 2007 Aug 14; [Epub ahead of print]
PMID: 17875315 [PubMed - as supplied by publisher]
5. The Prolongevity Effect of Resveratrol Depends on Dietary Composition and Calorie Intake in a Tephritid Fruit Fly.
Zou S, Carey JR, Liedo P, Ingram DK, Müller HG, Wang JL, Yao F, Yu B, Zhou A.
Exp Gerontol. 2009 Mar 2. [Epub ahead of print]
PMID: 19264118
6. Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA, Wang Y, Raederstorff D, Morrow JD, Leeuwenburgh C, Allison DB, Saupe KW, Cartee GD, Weindruch R, Prolla TA.
A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice.
PLoS ONE. 2008 Jun 4;3(6):e2264.
PMID: 18523577 [PubMed - in process]
7. Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction.
Mayers JR, Iliff BW, Swoap SJ.
FASEB J. 2008 Dec 4. [Epub ahead of print]
PMID: 19056839
8. Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets.
Rocha KK, Souza GA, Ebaid GX, Seiva FR, Cataneo AC, Novelli EL.
Food Chem Toxicol. 2009 Mar 16. [Epub ahead of print]
PMID: 19298841